Back to results
US 12,181,477 B2Granted
Methods of detecting prostate cancer
AssigneeImmunis.Ai, Inc.
InventorsAmin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
Life of this patent
Estimating the term…
Abstract
The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer
Claims10
A method for measuring the level of a marker in a sample from a subject, the method comprising the steps of:
- a) measuring the levels of five or more markers comprising ALPL, PI3, CXCR2, GPR97, and MMP9 in a population of the subject's macrophage cells;
- b) measuring the levels of the five or more markers in a population of the subject's non-phagocytic cells;
- wherein measuring levels of the five or more markers occurs prior to the subject receiving treatment for prostate cancer.
Dependencies are inferred from the claim text.